# EDGAR Filing Document

**Accession Number:** 0001815620
**File Stem:** 0001193125-25-276112
**Filing Date:** 2025-11
**Character Count:** 5744
**Document Hash:** 590a1da7c5d810711d4f3da10bca80e0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-276112.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001193125-25-276112

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20251112

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Opthea Ltd
- **CENTRAL INDEX KEY:** 0001815620
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39621
- **FILM NUMBER:** 251469304

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 4
- **STREET 2:** 650 CHAPEL STREET
- **CITY:** SOUTH YARRA
- **NON US STATE TERRITORY:** VICTORIA
- **PROVINCE COUNTRY:** C3
- **ZIP:** 3141
- **BUSINESS PHONE:** 61 3 9826 0399

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 4
- **STREET 2:** 650 CHAPEL STREET
- **CITY:** SOUTH YARRA
- **NON US STATE TERRITORY:** VICTORIA
- **PROVINCE COUNTRY:** C3
- **ZIP:** 3141

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of November 2025** 

**Commission File No. 001-39621**

## OPTHEA LIMITED
**(Translation of registrant's name into English)**

**C/- Prime Company Compliance, Level 9** 

**505 Little Collins Street** 

**Melbourne, VIC 3000** 

**Australia** 

**(Address of registrant's principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| 99.1 | [Press Release – 2025 AGM Results](d78039dex991.htm) |

---

------

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | |
|:---|:---|
| **OPTHEA LIMITED** | **OPTHEA LIMITED** |
| (Registrant) | (Registrant) |
| By: | /s/ Jeremy Levin |
| Name: | Jeremy Levin |
| Title: | Chief Executive Officer |

---

Date: November 12, 2025

## Exhibit 99.1

**Exhibit 99.1**![LOGO](g78039g1111065440443.jpg)

**Results of Annual General Meeting** 

**Melbourne, Australia, November 11, 2025**– Opthea Limited (ASX/NASDAQ: OPT) ("Opthea" or "the Company") advises that in accordance with Listing Rule 3.13.2 and section 251AA of the *Corporations Act 2001* (Cth), the results of the resolutions put to shareholders at today's Annual General Meeting are included in the attached document. All resolutions were carried by the requisite majority.

Authorised for release to ASX by the Board of Directors.

**Investor Inquiries** 

Email: <u>info@opthea.com</u> Web: <u>www.opthea.com</u>

Source: Opthea Limited

------

---

| | |
|:---|:---|
| **Opthea Limited**<br> **Annual General Meeting**<br> **Tuesday, 11 November 2025**<br> **Results of Meeting** | ![LOGO](g78039snap1.jpg) |

---

The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Resolution details** | **Resolution details** | **Instructions given to validly appointed proxies**<br>**(as at proxy close)** | **Instructions given to validly appointed proxies**<br>**(as at proxy close)** | **Instructions given to validly appointed proxies**<br>**(as at proxy close)** | **Instructions given to validly appointed proxies**<br>**(as at proxy close)** | **Number of votes cast on the poll**<br>**(where applicable)** | **Number of votes cast on the poll**<br>**(where applicable)** | **Number of votes cast on the poll**<br>**(where applicable)** | **Resolution<br>Result** |
| **Resolution** | **Resolution<br>Type** | **For** | **Against** | **Proxy's<br>Discretion** | **Abstain** | **For** | **Against** | **Abstain\*** | **Carried /<br>Not Carried** |
|  1 Re-election of Director – Dr. Jeremy Levin | Ordinary | 599,239,865<br>87.41% | 83,922,373<br>12.24% | 2,374,742<br>0.35% | 5515699 | 698,093,129<br>89.25% | 84,045,357<br>10.75% | 5519210 | Carried |
|  2 Re-election of Director – Ms. Kathy Connell | Ordinary | 658,734,520<br>96.09% | 21,911,178<br>3.19% | 4,898,282<br>0.72% | 5508699 | 759,711,324<br>97.18% | 22,034,162<br>2.82% | 5912210 | Carried |
|  3 Adoption of remuneration report | Ordinary | 500,204,619<br>73.28% | 181,361,174<br>26.57% | 990,462<br>0.15% | 5599011 | 597,661,672<br>76.71% | 181,476,089<br>23.29% | 5602522 | Carried |
|  4 Issue of options to Mr. Lawrence Gozlan under the NED Plan | Ordinary | 544,181,798<br>79.52% | 137,792,116<br>20.13% | 2,389,793<br>0.35% | 5401623 | 643,038,182<br>82.34% | 137,927,031<br>17.66% | 5405134 | Carried |
|  5 Issue of options to Ms. Kathy Connell under the NED Plan | Ordinary | 544,668,649<br>79.59% | 137,339,116<br>20.06% | 2,385,442<br>0.35% | 5372123 | 643,120,682<br>82.39% | 137,474,031<br>17.61% | 5775634 | Carried |
|  6 Issue of options to Dr. Jeremy Levin under the LTIP | Ordinary | 540,110,439<br>78.93% | 141,805,139<br>20.72% | 2,374,429<br>0.35% | 5475323 | 638,951,459<br>81.82% | 141,940,054<br>18.18% | 5478834 | Carried |

---

\* Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll. 

1/1